AU1705599A - Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood - Google Patents
Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral bloodInfo
- Publication number
- AU1705599A AU1705599A AU17055/99A AU1705599A AU1705599A AU 1705599 A AU1705599 A AU 1705599A AU 17055/99 A AU17055/99 A AU 17055/99A AU 1705599 A AU1705599 A AU 1705599A AU 1705599 A AU1705599 A AU 1705599A
- Authority
- AU
- Australia
- Prior art keywords
- hematopoietic
- cells
- methods
- peripheral blood
- facilitating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004027 cell Anatomy 0.000 title 1
- 230000003394 haemopoietic effect Effects 0.000 title 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 title 1
- 230000001483 mobilizing effect Effects 0.000 title 1
- 210000005259 peripheral blood Anatomy 0.000 title 1
- 239000011886 peripheral blood Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0648—Splenocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46434—Antigens related to induction of tolerance to non-self
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6682197P | 1997-11-26 | 1997-11-26 | |
US60066821 | 1997-11-26 | ||
US98651197A | 1997-12-08 | 1997-12-08 | |
US08986511 | 1997-12-08 | ||
US7286298A | 1998-05-05 | 1998-05-05 | |
US09072862 | 1998-05-05 | ||
PCT/US1998/025368 WO1999026639A1 (en) | 1997-11-26 | 1998-11-24 | Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1705599A true AU1705599A (en) | 1999-06-15 |
Family
ID=27371046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17055/99A Abandoned AU1705599A (en) | 1997-11-26 | 1998-11-24 | Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1705599A (en) |
WO (1) | WO1999026639A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8771663B2 (en) | 2000-04-18 | 2014-07-08 | Gentium Spa | Formulation having mobilising activity |
EP1147777A1 (en) * | 2000-04-18 | 2001-10-24 | Crinos Industria Farmacobiologica S.p.A. | Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors |
AU2009255663B2 (en) * | 2008-05-30 | 2015-05-14 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
US11291686B2 (en) | 2008-05-30 | 2022-04-05 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
US8632768B2 (en) * | 2008-05-30 | 2014-01-21 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
US8563307B2 (en) | 2009-02-24 | 2013-10-22 | James Wang | Treatment of immunosuppression-related disorders |
US8679474B2 (en) | 2010-08-04 | 2014-03-25 | StemBios Technologies, Inc. | Somatic stem cells |
TWI614340B (en) | 2011-09-28 | 2018-02-11 | 幹細胞生物科技股份有限公司 | Somatic stem cells and method of preparing same |
TWI687519B (en) | 2012-12-06 | 2020-03-11 | 美商幹細胞生物科技股份有限公司 | Lgr5+ somatic stem cells |
EP2746769A1 (en) | 2012-12-21 | 2014-06-25 | Stembios Technologies, Inc. | Method for evaluating effect of action on subject based on stem celldynamics |
JP6581758B2 (en) * | 2013-06-24 | 2019-09-25 | ステムバイオス テクノロジーズ,インコーポレイテッド | Stem cells and methods for acquiring the data |
EP3220929A4 (en) * | 2014-11-19 | 2018-06-27 | Stembios Technologies, Inc. | Somatic stem cells for treating bone defects |
CN111778212B (en) * | 2020-07-08 | 2022-09-27 | 因诺伟(北京)生物医疗科技有限公司 | Preparation method and application of mobilized hematopoietic stem cell plasma exosome |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554512A (en) * | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
US5635156A (en) * | 1993-09-13 | 1997-06-03 | University Of Pittsburgh | Non-lethal methods for conditioning a recipient for bone marrow transplantation |
-
1998
- 1998-11-24 AU AU17055/99A patent/AU1705599A/en not_active Abandoned
- 1998-11-24 WO PCT/US1998/025368 patent/WO1999026639A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999026639A1 (en) | 1999-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2369695A (en) | Improved blood contact surfaces employing natural subendothelial matrix and method for making and using the same | |
AU2892295A (en) | Stem cell immobilisation | |
EP0788165A3 (en) | Storage cell arrangement and method for making the same | |
AU3790399A (en) | Blood set and chamber | |
AU9231998A (en) | Antigen presenting mesenchymal stem cells | |
AU7383398A (en) | Therapeutic glasses and method for using the same | |
AU4397597A (en) | Novel phytase and process for the preparation thereof | |
AU7083398A (en) | Solar battery and process for manufacturing the same | |
IL109963A0 (en) | E2-f1 enzyme and methods for the isolation, purification and use thereof | |
AU2045499A (en) | Cuff electrode and method for manufacturing the same | |
AU1705599A (en) | Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood | |
AU2418499A (en) | Org-5222 in the treatment of depression | |
AU5432798A (en) | Materials and procedures for the purification of cells | |
AU6322598A (en) | Case for combustible materials and methods for making and using the same | |
EP0662512A3 (en) | Human hematopoietic stem cells. | |
AU7180294A (en) | Reaction cell for protein sequencer and the like | |
AU9732098A (en) | Hematopoietic stem cells | |
AU2087799A (en) | Diagnostic and therapeutic methods based upon valpha24jalphaq t cells | |
AU4520101A (en) | Lung stem cells and lung regeneration | |
AU9569998A (en) | Photo-spectrometers, methods of use and manufacture | |
ZA972247B (en) | Combination of enzymes for the destruction of proliferative cells. | |
AU4317597A (en) | Hematopoietic stem cells and methods for generating such cells | |
AU1083501A (en) | Antibiotic-metal complex and methods | |
AU6300898A (en) | Well treatment with particles | |
AU1220599A (en) | Method for the production and use of dendritic cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |